Dr. Gross brings over 30 years experience in the design, development and commercialization of Medical devices. He currently serves as CEO of SummatiX, a joint venture between Canary Medical and BioScience Managers and was previously Senior Vice President R&D and CTO at CareFusion, Senior Vice President R&D at Angiotech Pharmaceuticals, and held a variety of executive R&D leadership roles within Medtronic’s Heart Valve and Spinal Biologics organizations. He has over 40 patents and patent applications covering cardiovascular, orthopedics, wound healing, and smart implant products and technologies.
Dr. Gross received his B.S. in Mechanical Engineering from the Georgia Institute of Technology, his M.S. in Biomedical Engineering from the University of Houston, and his PhD in Biomedical Engineering from the University of Memphis focused on cardiovascular fluid mechanics. He is a Fellow of the American Institute of Medical and Biological Engineering and served on Advisory Boards for both the Georgia Institute of Technology and University of Memphis Biomedical Engineering Departments.
Mr. Kochubeevsky specializes in commercialization of Medical Software Systems by leading the product development life cycle from early product definition stage, through development and V&V, to market launch. In recent years he successfully delivered a number of medically regulated products used internationally in fields of Embryology and Cancer Diagnostics. Mr. Kochubeevsky has a software development background comprising over 10 years of team leading, and hands on development of products for Medical, Financial and Electronics industries with many of the products developed for Start-Ups at various funding levels.
Mr. Kochubeevsky received his B.Sc. in Electrical Engineering from Bar-Ilan University focused on Telecommunications and Signal Processing, and his MBA from the Technion (Israel Institute of Technology) focused on Entrepreneurship and Management of Technology Oriented Companies. Mr. Kochubeevsky is fluent in three languages.